SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:hik-936"
 

Search: onr:"swepub:oai:DiVA.org:hik-936" > Oncolysis of vascul...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Au, Gough GThe University of Newcastle (author)

Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21.

  • Article/chapterEnglish2005

Publisher, publication year, extent ...

  • 2005
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:hik-936
  • https://urn.kb.se/resolve?urn=urn:nbn:se:hik:diva-936URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Cultured melanoma cell lines despite exhibiting similar in vitro morphology, display significant phenotypic and growth rate differences when propagated as in vivo xenografts. Previously we have shown that Coxsackievirus A21 (CVA21) lytically infects in vitro cultures of malignant melanoma cells and is efficient at reducing the tumor burden of mice bearing slow-growing SK-Mel-28 melanoma xenografts. The oncolytic activity of CVA21 against in vivo melanoma xenografts, which possess rapid growth rates and more extensive vascular structure than SK-Mel-28 xenografts warrants further investigation. In the present study we evaluated the oncolytic action of CVA21 against rapidly growing melanoma xenografts (ME4405) which exhibit a highly vascular phenotype. Flow cytometric analysis indicated that in vitro cultures of ME4405 cells expressed comparable levels of the CVA21 cellular receptors, ICAM-1 (intercellular adhesion molecules-1) and DAF (decay accelerating factor) to SK-Mel-28 cells. Despite similar levels of CVA21 receptor expression, SK-Mel-28 cells appear to be more susceptible to viral lysis than ME4405 cells, even though the kinetics of virus replication in both lines was comparable. Intratumoral, intraperitoneal or intravenous administration of CVA21 were equally effective in reducing the tumor volume of ME4405 xenografts in immunodeficient mice, and provides further evidence for the use of CVA21 as a novel oncolytic agent against varying phenotypes of malignant melanoma.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Lindberg, A MichaelHögskolan i Kalmar,Naturvetenskapliga institutionen(Swepub:lnu)nlimi (author)
  • Barry, Richard DThe University of Newcastle (author)
  • Shafren, Darren RThe University of Newcastle (author)
  • The University of NewcastleNaturvetenskapliga institutionen (creator_code:org_t)

Related titles

  • In:International Journal of Oncology26:6, s. 1471-61019-64391791-2423

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Au, Gough G
Lindberg, A Mich ...
Barry, Richard D
Shafren, Darren ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Microbiology in ...
Articles in the publication
International Jo ...
By the university
Linnaeus University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view